drugset / Trial / NCT06281899
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Phase 4
Unknown
200 enrolled
Anemia Working Group Romania
Carol Davila University of Medicine and Pharmacy · collabDr Carol Davila Teaching Hospital of Nephrology, Nephrology Department, Bucharest, Romania · collabSf Ioan Emergency Clinical Hospital, Nephrology and Dialysis Department, Bucharest, Romania · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective multicenter randomized controlled trial with a total duration of 36 months aiming to evaluate the effectiveness and the safety of low protein diet on top of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and renin-angiotensin-aldosterone inhibitors (RAASi) in reducing the progression of chronic kidney disease in patients with type 2 Diabetes Mellitus
Timeline
- Start
- 2022-01-01
- Primary completion
- 2024-12-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dapagliflozin | Small molecule | 10 mg | — |